Please login to the form below

Not currently logged in
Email:
Password:

Cytori appoints David Rickey as chairman

Replaces Lloyd Dean who will concentrate on CEO position at Dignity Health

David Rickey, Cytori San Diego-based Cytori Therapeutics has named David Rickey as the successor to its current chairman of the board Lloyd Dean.

Rickey brings more than a decade of experience with Cytori to the position, having served on the board of directors at the cell therapy-focused biotech for 13 years.

In addition to this role, he has served in several senior positions over the course of the past few years, primarily at technology companies.

This includes periods as president, CEO and chairman of Applied Micro Circuits Corporation; director of AMI Semiconductor; and director of Netlist.

His predecessor as Cytori chairman, Dean, will continue to serve as an independent member of the board of directors in addition to his role as president and CEO of healthcare provider Dignity Health.

According to Cytori, Dean requested the move to cope with Dignity Health's preparations for the implementation of the Affordable Care Act in the US in 2014.

“We are grateful to Mr Dean for his leadership and service as Chairman for the past two years, and look forward his continued service to Cytori and our shareholders into the future,” said Chris Calhoun, CEO of Cytori.

11th July 2013

From: Research, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...